Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-12-18

Clinical Trial Update: Targeted Temperature Management After Intracerebral Hemorrhage [Phase 2]

View source ↗

Summary

A Phase 2 trial from Thomas Jefferson University is evaluating targeted temperature management after intracerebral hemorrhage; no results are reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Thomas Jefferson University | Conditions: Cerebral Hemorrhage, Hypothermia | Phase 2 | Status: UNKNOWN